硫必利治疗肿瘤相关性疼痛的双盲研究（作者译）
[Double blind study of tiapride in neoplasia-related pains (author's transl)].
作者信息
Dilhuydy J M, Miquel Y, Oyon J
出版信息
Sem Hop. 1979;55(43-44):2020-1.
PMID:233444
Abstract
The antalgic effects of tiapride used by intravenous way have been evaluated in a randomized study on 30 patients with neoplasia-related pains. We noticed a partial or a complete positive response in 60 % of the cases when tiapride is given at a dose of 300 mg/day. The average efficient period was about four hours. Tolerance was good.
摘要
在一项针对30例肿瘤相关性疼痛患者的随机研究中，评估了静脉注射硫必利的镇痛效果。我们注意到，当硫必利以300毫克/天的剂量给药时，60%的病例出现了部分或完全的阳性反应。平均有效时长约为4小时。耐受性良好。
Zotero 插件